(Q90043146)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

title

Naringin sensitizes human prostate cancer cells to paclitaxel therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

Suat Erdogan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Oguzhan Doganlar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Zeynep B Doganlar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Kader Turkekul

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

publication date

28 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

published in

Prostate international

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

page(s)

126-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

10 April 2020

cites work

1 reference

12 December 2020

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

12 December 2020

Microtubules as a target for anticancer drugs

1 reference

12 December 2020

Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes

1 reference

12 December 2020

Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats

1 reference

12 December 2020

Dietary polyphenols may affect DNA methylation

1 reference

12 December 2020

Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression

1 reference

12 December 2020

Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype

1 reference

12 December 2020

Naringin-induced p21WAF1-mediated G(1)-phase cell cycle arrest via activation of the Ras/Raf/ERK signaling pathway in vascular smooth muscle cells

1 reference

12 December 2020

Drug combination studies and their synergy quantification using the Chou-Talalay method

1 reference

12 December 2020

Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells

1 reference

12 December 2020

Synergistic effects of irinotecan and flavonoids on Ehrlich ascites tumour-bearing mice

1 reference

12 December 2020

PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control

1 reference

12 December 2020

Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells

1 reference

12 December 2020

The role of Snail in prostate cancer

1 reference

12 December 2020

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway

1 reference

12 December 2020

Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer

1 reference

12 December 2020

Preclinical evidence for the pharmacological actions of naringin: a review

1 reference

12 December 2020

PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.

1 reference

12 December 2020

Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF‑κB/COX‑2‑caspase-1 pathway in HeLa cervical cancer cells

1 reference

12 December 2020

Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line.

1 reference

12 December 2020

Signal transduction in cancer

1 reference

12 December 2020

In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment

1 reference

12 December 2020

Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells

1 reference

12 December 2020

Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway

1 reference

12 December 2020

Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat.

1 reference

12 December 2020

Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.

1 reference

12 December 2020

Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma

1 reference

12 December 2020

Induction of Human Hepatocellular Carcinoma HepG2 Cell Apoptosis by Naringin.

1 reference

12 December 2020

The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling.

1 reference

12 December 2020

Naringin protects against lipopolysaccharide-induced cardiac injury in mice

1 reference

12 December 2020

Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.

1 reference

12 December 2020

Contemporary agents in the management of metastatic castration-resistant prostate cancer.

1 reference

12 December 2020

10.1016/J.PRNIL.2017.11.001

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30505814%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

PubMed publication ID

30505814

1 reference